PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, today announced that it has appointed five new consulting experts, including several former U.S. Food and Drug Administration (FDA) reviewers, to support its growth. The consultants, who have more than 100 years of combined experience in regulatory affairs and product development, are based in PAREXEL's newly-established Washington, D.C.-area office, located in Bethesda, Maryland.
NOT FOR REPRINT
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.